TTR and Alzheimer disease: Taking into account that, to date, there are no effective disease-slowing or -modifying treatments for AD, the discovery that TTR stabilization, through the use of small-molecule compounds, enhances the TTR/Aβ interaction, opens a new avenue that relies on the recovery of TTR activity, without affecting gene expression.